{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:00Z","timestamp":1787020740284,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second-trimesters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study was conducted in Arash Hospital and Nilou Laboratory in 2017\u20132018. The screening test was conducted on 90 PCOS and 90 healthy mothers. Finally, the first and second-trimester screening was compared between the two groups using Chi-square, Mann-Whitney\u2019s U and students T tests and regression model by SPSS 21. P\u2009&lt;\u20090.05 was considered as statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Free Beta-Human Chorionic Gonadotropin (Free-\u03b2-HCG) (P\u2009=\u20090.04), inhibin-A (P\u2009=\u20090.001) and Alpha Fetoprotein (AFP) (P\u2009=\u20090.02) levels were higher in the PCOS women comparing to the healthy women but there was no significant difference between the mean of HCG, Plasma Protein A (PAPP-A), and Unconjugated Estriol (UE3) between the two groups. Pre-eclampsia (P\u2009&lt;\u20090.001) and trisomy 18 risks in quad screening were higher in the PCOS women (P\u2009=\u20090.002\n                      <jats:bold>)<\/jats:bold>\n                      than the control group; however, trisomy 13, trisomy 18 and trisomy 21 risks, Smith-Lemli-Opitz Syndrome (SLOS) and Neural Tube Defect (NTD) risks were not different between the two groups. The logistic regression model showed that the first- and second-trimester screening of aneuploidywas related to PCOS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      There was a significant difference in the mean of free\n                      <jats:bold>-<\/jats:bold>\n                      \u03b2-HCG, inhibin-A, AFP level, and the risks of pre-eclampsia, SLOS and trisomy 18 between the two groups but no significant association was found in the mean of HCG, PAPP-A, UE3, NTD and other aneuploidies between the two groups. PCOS may affect the first- and second-trimester screening tests and pregnancy health. It may also require correction in the calculation of risks related to the first- and second-trimester screening for aneuploidy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-023-01251-w","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T12:02:41Z","timestamp":1692619361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters"],"prefix":"10.1186","volume":"16","author":[{"given":"Narjes Hassan","family":"Haivadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahideh","family":"Jahanian Sadatmahalleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-509X","authenticated-orcid":false,"given":"Fatemeh","family":"Razavinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Younesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-9926","authenticated-orcid":false,"given":"Saeideh","family":"Ziaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"147","key":"1251_CR1","first-page":"159","volume":"27","author":"S Mehrabadi","year":"2017","unstructured":"Mehrabadi S, Jahanian Sadatmahalleh S, Kazemnejad A. Association of Depression and anxiety with cognitive function in patients with polycystic ovary syndrome. J Mazandaran Univ Med Sci. 2017;27(147):159\u201370.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"1","key":"1251_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","volume":"373","author":"DH Abbott","year":"2013","unstructured":"Abbott DH, Nicol LE, Levine JE, Xu N, Goodarzi MO, Dumesic DA. Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373(1):21\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"1251_CR3","unstructured":"Cunningham F, Leveno K, Bloom S, Dashe J, Hoffman B, Casey B, Spong CY. Williams Obstetrics 24\/E: McGraw Hill Professional; 2018."},{"issue":"2","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2753.2007.00831.x","volume":"14","author":"HL Hwa","year":"2008","unstructured":"Hwa HL, Yen MF, Lin CL, Ko TM, Hsieh FJ, Chen THH. Cost-effectiveness analysis of triple test in second\u2010trimester maternal serum screening for Down\u2019s syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women. J Eval Clin Pract. 2008;14(2):191\u20137.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2265.1993.tb00979.x","volume":"38","author":"S Tovanabutra","year":"1993","unstructured":"Tovanabutra S, Illingworth P, Ledger W, Glasier A, Baird D. The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy. Clin Endocrinol. 1993;38(1):101\u20137.","journal-title":"Clin Endocrinol"},{"key":"1251_CR6","doi-asserted-by":"crossref","unstructured":"Canick JA, Kellner LH, editors. First trimester screening for aneuploidy: serum biochemical markers. Seminars in Perinatology. Elsevier; 1999.","DOI":"10.1016\/S0146-0005(99)80002-0"},{"issue":"9","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","volume":"17","author":"NJ Wald","year":"1997","unstructured":"Wald NJ, Hackshaw AK. Combining Ultrasound and Biochemistry in First-Trimester Screening for Down\u2019s syndrome. Prenat Diagn. 1997;17(9):821\u20139.","journal-title":"Prenat Diagn"},{"issue":"8807","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/0140-6736(92)92073-O","volume":"339","author":"K Spencer","year":"1992","unstructured":"Spencer K, Macri J, Aitken D, Connor J. Free \u03b2-hCG as first-trimester marker for fetal trisomy. The Lancet. 1992;339(8807):1480.","journal-title":"The Lancet"},{"issue":"5","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-0528.1996.tb09765.x","volume":"103","author":"NJ Wald","year":"1996","unstructured":"Wald NJ, George L, Smith D, Densem J, Pettersonm K. Serum screening for Down\u2019s syndrome between 8 and 14 weeks of pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. 1996;103(5):407\u201312.","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"5","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","volume":"108","author":"JA Canick","year":"2006","unstructured":"Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, et al. Comparison of serum markers in first-trimester Down syndrome screening. Obstet Gynecol. 2006;108(5):1192\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000020986","volume":"15","author":"H-J Jou","year":"2000","unstructured":"Jou H-J, Shyu M-K, Chen S-M, Shih J-C, Hsu J-J, Hsieh F-J. Maternal serum screening for down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an asian population. Fetal Diagn Ther. 2000;15(2):108\u201311.","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1471-0528.2008.02010.x","volume":"116","author":"Y-MD Lo","year":"2009","unstructured":"Lo Y-MD. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG: An International Journal of Obstetrics & Gynaecology. 2009;116(2):152\u20137.","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"1","key":"1251_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12891\/ceog1703.2015","volume":"42","author":"S Hacivelioglu","year":"2015","unstructured":"Hacivelioglu S, Uysal A, Gungor A, Gencer M, Cakir D, Cosar E. The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness. Clin Exp Obstet Gynecol. 2015;42(1):32\u20135.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE\/ Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE\/, ASRM-Sponsored PCOS Con-sensus Workshop Group. Revised 2003 consensuson diagnostic criteria and long-term health risks re-lated to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"1251_CR15","unstructured":"Cunningham F, Leveno K, Bloom S, Dashe J, Hoffman B, Casey B, Spong CY. Williams Obstetrics 24\/E. McGraw Hill Professional; 2018. pp. 336\u20137."},{"key":"1251_CR16","first-page":"834","volume-title":"Public Health","author":"H Hatami","year":"2005","unstructured":"Hatami H, Razavi M, Eftekhar H, Majlesi F. Public Health. Iran: Arjmand; 2005. p. 834."},{"issue":"11","key":"1251_CR17","first-page":"1073","volume":"34","author":"MF Karsli","year":"2014","unstructured":"Karsli MF, Gultekin IB, Cakmak B, Yeral MI, Seckin KD, Alt Nboga O, Kucukozkan T. Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome? Obstet Gynecol. 2014;34(11):1073\u20136.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1258\/000456306777695726","volume":"43","author":"N Jassam","year":"2006","unstructured":"Jassam N, Jones C, Briscoe T, Horner J. The hook effect: a need for constant vigilance. Ann Clin Biochem. 2006;43(4):314\u20137.","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"1251_CR19","first-page":"1491","volume":"15","author":"E Seregni","year":"1995","unstructured":"Seregni E, Botti C, Bombardieri E. Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms. Anticancer Res. 1995;15(4):1491\u20139.","journal-title":"Anticancer Res"},{"key":"1251_CR20","unstructured":"Cunningham F, Leveno K, Bloom S, Dashe J, Hoffman B, Casey B, Spong CY. Williams Obstetrics 24\/E: McGraw Hill Professional; 2018, P. 125."},{"issue":"10","key":"1251_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","volume":"103","author":"G Paradisi","year":"2001","unstructured":"Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410\u20135.","journal-title":"Circulation"},{"issue":"05","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-2008-1071168","volume":"7","author":"K Ohama","year":"1997","unstructured":"Ohama K, Nagase H, Ogino K, Tsuchida K, Tanaka M, Kubo M, et al. Alpha-fetoprotein (AFP) levels in normal children. Eur J Pediatr Surg. 1997;7(05):267\u20139.","journal-title":"Eur J Pediatr Surg"},{"issue":"2","key":"1251_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000335677","volume":"31","author":"F Bredaki","year":"2012","unstructured":"Bredaki F, Poon L, Birdir C, Escalante D, Nicolaides K. First-trimester screening for neural tube defects using alpha-fetoprotein. Fetal Diagn Ther. 2012;31(2):109\u201314.","journal-title":"Fetal Diagn Ther"},{"issue":"6072","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/321779a0","volume":"321","author":"N Ling","year":"1986","unstructured":"Ling N, Ying S-Y, Ueno N, Shimasaki S, Esch F, Hotta M, et al. Pituitary FSH is released by a heterodimer of the \u03b2-subunits from the two forms of inhibin. Nature. 1986;321(6072):779\u201382.","journal-title":"Nature"},{"key":"1251_CR25","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Dash JS, Haffman BL, Casey BM, Spong CY. Williams Obstetrics, 25th edition, 2019; 848\u2013849."},{"issue":"1","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.23736\/S2724-606X.21.04758-4","volume":"74","author":"M D\u2019Alterio","year":"2022","unstructured":"D\u2019Alterio M, Sigilli M, Succu G. Minerva Obstet Gynecol. 2022;74(1):45\u201359.","journal-title":"Minerva Obstet Gynecol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01251-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:38:57Z","timestamp":1700357937000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01251-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01251-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Tarbiat Modares University, Tehran\/Iran on May 23th, 2016 (IR.TMU.REC.1395.369).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"167"}}